Tenet ended the fourth quarter of 2018 with a net loss attributable to shareholders of $5 million, compared to the $229 million net loss the company recorded in the same period a year prior.
Tenet saw its revenue slide in the fourth quarter of 2018 to $4.62 billion, down from $4.98 billion in the same period of 2017. However, that’s above the $4.51 billion estimate from financial data and software company FactSet, according to MarketWatch.
The website states that Tenet stock overall has gained 25.6 percent in the last 12 months.
More articles on healthcare finance:
RCM tip of the day: Teach staff, patients how to use new software
ACA enrollees appeal less than 1% of denied claims, analysis finds
Tax-exempt hospitals to get an IRS checkup on federal law compliance
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
